Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

about

Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.

P2860

Q51779283-B1CA19F4-0AF1-46A4-91A3-29E066C75718

P2860

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

Item

http://www.wikidata.org/entity/Q36712182

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@ast

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@en

type

Item

label

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@ast

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@en

prefLabel

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@ast

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@en

P1476

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

@en

P2093

Atul C Mehta

http://www.w3.org/2001/XMLSchema#string

Khawaja S Zaki

http://www.w3.org/2001/XMLSchema#string

Marie Budev

http://www.w3.org/2001/XMLSchema#string

Olufemi Akindipe

http://www.w3.org/2001/XMLSchema#string

Zahra Aryan

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry

European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation.

The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.

Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.

Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis.

P304

249-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5500/WJT.V6.I1.249

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27011924

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant

P932

4801802

http://www.w3.org/2001/XMLSchema#string

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

about

P2860

P2860

Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932